Evidence map›Paper›PMID 31959771›Full record

ArticleScientific reports2020

An Optimised Protocol Harnessing Laser Capture Microdissection for Transcriptomic Analysis on Matched Primary and Metastatic Colorectal Tumours.

Chin-Ann J Ong, Qiu Xuan Tan, Hui Jun Lim, Nicholas B Shannon, Weng Khong Lim, Josephine Hendrikson, Wai Har Ng, Joey W S Tan, Kelvin K N Koh, Seettha D Wasudevan and 10 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Shape decomposition algorithms for laser capture microdissection.Algorithms for molecular biology : AMB · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Chin-Ann J Ong *Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.ORCID http://orcid.org/0000-0003-4573-7738
Qiu Xuan Tan *Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.ORCID http://orcid.org/0000-0002-5700-1739
Hui Jun Lim *Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Nicholas B ShannonDepartment of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Weng Khong LimCancer and Stem Cell Biology, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.ORCID http://orcid.org/0000-0003-4391-1130
Josephine HendriksonDepartment of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Wai Har NgDepartment of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Joey W S TanDepartment of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Kelvin K N KohDepartment of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Seettha D WasudevanDepartment of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Cedric C Y NgDivision of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.ORCID http://orcid.org/0000-0002-7150-4674
Vikneswari RajasegaranDivision of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Tony Kiat Hon LimDepartment of Anatomical Pathology, Singapore General Hospital, 20 College Road, Singapore, S169856, Singapore.
Choon Kiat OngDivision of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.ORCID http://orcid.org/0000-0001-6402-4288
Oi Lian KonDivision of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Bin Tean TehDivision of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.ORCID http://orcid.org/0000-0003-1514-1124
Grace H C TanDepartment of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Claramae Shulyn ChiaDepartment of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Khee Chee SooDepartment of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore.
Melissa C C TeoDepartment of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, S169610, Singapore. melissa.teo.c.c@singhealth.com.sg.
National Cancer Centre Singapore · SGDuke-NUS Medical School · SGSingapore General Hospital · SGSingHealth · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generation of large amounts of genomic data is now feasible and cost-effective with improvements in next generation sequencing (NGS) technology. Ribonucleic acid sequencing (RNA-Seq) is becoming the preferred method for comprehensively characterising global transcriptome activity. Unique to cytoreductive surgery (CRS), multiple spatially discrete tumour specimens could be systematically harvested for genomic analysis. To facilitate such downstream analyses, laser capture microdissection (LCM) could be utilized to obtain pure cell populations. The aim of this protocol study was to develop a methodology to obtain high-quality expression data from matched primary tumours and metastases by utilizing LCM to isolate pure cellular populations. We demonstrate an optimized LCM protocol which reproducibly delivered intact RNA used for RNA sequencing and quantitative polymerase chain reaction (qPCR). After pathologic annotation of normal epithelial, tumour and stromal components, LCM coupled with cDNA library generation provided for successful RNA sequencing. To illustrate our framework's potential to identify targets that would otherwise be missed with conventional bulk tumour sequencing, we performed qPCR and immunohistochemical technical validation to show that the genes identified were truly expressed only in certain sub-components. This study suggests that the combination of matched tissue specimens with tissue microdissection and NGS provides a viable platform to unmask hidden biomarkers and provides insight into tumour biology at a higher resolution.

Indexed as

Colorectal NeoplasmsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingHumansKrukenberg TumorLaser Capture MicrodissectionOvarian NeoplasmsSequence Analysis, RNASpecimen HandlingWorkflow

Identifiers

PMID31959771
PMCPMC6971024
OpenAlexW3005420555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.